Document

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-286161) and on Form F-3 (No. 333-278506) of Sanofi of our reports dated February 17, 2026 relating to the financial statements as of December 31, 2025 and 2024, and for the two years in the period ended December 31, 2025, and the effectiveness of internal control over financial reporting as of December 31, 2025 and our report dated February 23, 2024, except for the effects of the classification as discontinued operations of Opella described in Note D.1.1.1, relating to the financial statements as of December 31, 2023 and for the year ended December 31, 2023, as to which the date is February 13, 2025, which appear in this Form 20-F.